RNA
RNA
NASDAQ · Biotechnology

Avidity Biosciences Inc

$13.09
-0.11 (-0.83%)
As of Mar 25, 9:44 PM ET ·
Financial Highlights (FY 2026)
Revenue
14.86M
Net Income
-439,382,306
Gross Margin
Profit Margin
-2,957.7%
Rev Growth
+5.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.7% 39.7%
Operating Margin -3,477.4% -3,129.7% -24.8% -24.2%
Profit Margin -2,957.7% -2,809.8% -27.6% -21.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 14.86M 14.11M 2.36B 2.44B
Gross Profit 936.04M 969.30M
Operating Income -516,800,763 -441,668,110 -583,930,228 -590,749,120
Net Income -439,382,306 -375,504,772 -651,372,475 -517,686,100
Gross Margin 39.7% 39.7%
Operating Margin -3,477.4% -3,129.7% -24.8% -24.2%
Profit Margin -2,957.7% -2,809.8% -27.6% -21.2%
Rev Growth +5.3% +5.3% +6.9% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.58B 3.15B
Total Equity 5.59B 5.69B
D/E Ratio 0.46 0.55
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -513,142,555 -462,905,163 -865,943,607 -944,563,645
Free Cash Flow -400,975,764 -475,814,962